Elsevier

Diabetes & Metabolism

Volume 38, Issue 5, November 2012, Pages 450-457
Diabetes & Metabolism

Original article
Ophdiat®: Five-year experience of a telemedical screening programme for diabetic retinopathy in Paris and the surrounding areaOphdiat® : cinq ans d’expérience d’un programme de dépistage de rétinopathie diabétique par télémédicine à Paris et en Île-de-France

https://doi.org/10.1016/j.diabet.2012.05.003Get rights and content

Abstract

Aim

This report describes our 5 years of experience with the ophthalmological diabetes telemedical network Ophdiat®, designed to screen for diabetic retinopathy.

Methods

Seventeen hospitals, 11 primary healthcare centres and two prisons in the Paris area were gradually equipped with a non-mydriatic funduscopic camera between June 2004 and December 2009. Photos were taken by trained orthoptists and nurses, and interpreted by an average of seven certified ophthalmologists. The software was updated twice in 2008.

Results

In all, 38,596 patients were screened during 51,741 examinations between June 2004 and December 2009. Of these patients, 13,726 (26.55%) were referred to an ophthalmologist because of unreadable photographs (9.94%), advanced stages of retinopathy (14.71%) or concomitant eye diseases (1.90%). Patients screened in hospitals and prisons exhibited a greater prevalence of retinopathy and at more advanced stages.

Conclusion

Telemedicine is a screening method that is well adapted for diabetic patients. In view of the increasing number of such patients and the decreasing number of ophthalmologists, expansion of the Ophdiat® screening network is desirable.

Résumé

But

Rapporter l’expérience à cinq ans du réseau de télémédicine Ophdiat®, créé pour le dépistage de la rétinopathie diabétique.

Méthodes

Dix-sept hôpitaux, 11 centres médicaux de santé et deux prisons en Île-de-France ont été progressivement équipés d’un rétinographe non-mydriatique entre juin 2004 et décembre 2009. Les photographies du fond d’œil ont été prises par des orthoptistes et des infirmières qualifiées et interprétées par une moyenne de sept ophtalmologistes certifiés. Le logiciel a été mis à jour à deux reprises en 2008.

Résultats

Au total, 38 596 patients ont été dépistés lors de 51 741 examens entre juin 2004 et décembre 2009. Parmi ces patients, 13 726 (26,55 %) ont été adressés chez un ophtalmologiste pour des clichés non interprétables (9,94 %), des stades évolués de rétinopathie diabétique (14,71 %) ou une pathologie oculaire associée (1,90 %). Une prévalence plus importante de rétinopathie diabétique et des stades évolués a été trouvée chez les patients dépistés dans les hôpitaux et les prisons.

Conclusion

La télémédecine est une méthode de dépistage appropriée pour les patients diabétiques. Devant le nombre croissant des patients et le nombre d’ophtalmologistes en baisse, l’expansion du réseau Ophdiat® est souhaitable.

Introduction

Screening for diabetic retinopathy helps towards the early diagnosis of advanced stages of the disease, which is of crucial importance for choosing the appropriate treatment and preventing further visual loss [1], [2]. According to both international recommendations and those of the French National Health Authority, the Haute Autorité de Santé (HAS), an annual examination of the ocular fundus should be done in diabetic patients who have either no documented or mild retinopathy [1], [3], [4], [5], [6]. Screening for retinopathy should be done by retinography, as it is a more sensitive technique than indirect ophthalmoscopy [7], [8], [9]. Although retinal photographs may be taken by doctors and paramedical personnel outside of ophthalmological centres, the photos have to be interpreted by a retinal specialist [10]. The characteristics of diabetic retinopathy, combined with the progress made in data-transfer systems, constitute an optimal basis for telemedicine [11]. Telemedical networks that screen for diabetic retinopathy are, in fact, already working in several countries, and good results have been reported [12], [13], [14], [15], [16], [17], [18]. However, demographic studies have found that only 40 to 60% of the diabetic population undergoes regular ocular screening [19], [20].

The present report describes our 5-year experience of the Ophthalmology Diabetes Telemedicine Network (Ophdiat®), which covers Paris and the surrounding area known as the Île-de-France.

Section snippets

Methods

The Ophdiat® network was created in 2004 with the aim of improving the ophthalmological screening of diabetic patients in the Île-de-France area. The screening centres that make up this network are linked via a central server to an ophthalmological reading centre. The organization and details of the network have been described elsewhere [21] and, hence, are only briefly covered here.

From 24 June 2004 to 31 December 2009, an ever-increasing number of hospitals and primary healthcare centres (

Results

By 31 December 2009, 51,741 screening examinations had been completed for 38,596 patients in the Île-de-France area. During the 5.5 years of the study period beginning in June 2004, the number of screening examinations and new patients increased constantly (Fig. 2).

Around 73% of all patients were diagnosed as having mild DR or none at all, and annual screening by a funduscopic camera was recommended. However, not all of these patients came to be screened the year after their initial

Discussion

Telemedicine is considered an optimal means of screening for DR [11]. The Ophdiat® network was designed to cover Paris and the entire surrounding Île-de-France area, which together comprise nearly 12 million inhabitants (11,659,260). According to a representative national sample of diabetic patients for the period 2007–2010, the prevalence of diabetes in this population was 3 to 6% and expected to increase [20]. However, the number of ophthalmologists [n = 1358, including 568 who are intra muros

Disclosure of interest

The authors declare that they have no conflicts of interest concerning this article.

Acknowledgements

The Ophdiat® network is supported by the Organisme pour la Prévention de la Cécité (Organization for the Prevention of Blindness) and the Valentin Haüy Association. The following institutions are participants in the Ophdiat® network:

  • hôpital Avicenne, Bobigny: Pr G. Réach, Dr R. Cohen, Diabetology Department; Pr G. Chaine, Ophthalmology Department;

  • hôpital Bichat, Paris: Pr M. Marre, Diabetology Department; Pr I. Cochereau, Ophthalmology Department;

  • hôpital Cochin, Paris: Pr J. Timsit, Diabetology

References (35)

  • M. Perrier et al.

    Comparison of two, three and four 45 degrees image fields obtained with the Topcon CRW6 nonmydriatic camera for screening for diabetic retinopathy

    Can J Ophthalmol

    (2003)
  • A. Chabouis et al.

    Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centers

    Diabetes Metab

    (2009)
  • Screening guidelines for diabetic retinopathy. American College of Physicians, American Diabetes Association, and...
  • Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study...
  • National Health Service Scotland. Diabetic Retinopathy Screening Implementation Group. Diabetic retinopathy screening...
  • UK National Screening Committee. Essential Elements in Developing a Diabetic Retinopathy Screening Programme. Workbook...
  • P. Massin et al.

    Detection, monitoring and treatment of diabetic retinopathy. Recommendations by ALFEDIAM formulated by a committee comprising the above experts, and validated by the board of directors and scientific board of ALFEDIAM

    Diabetes Metab

    (1996)
  • Cited by (0)

    View full text